Westport talks meth-resistant pseudoephedrine Zephrex-D

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

AUDIO Q&A: Westport VP and general manager Paul Hemings spoke with DSN about the company's introduction of Zephrex-D, a meth-resistant pseudoephedrine product, to market. Beyond taking a bite out of the $23.5 billion methamphetamine trade, Hemings discussed the benefits of having Zephrex-D behind the pharmacy counter.

Smartphone users click here.